SALMON, J.
This case arises out of a survivorship/wrongful-death lawsuit in which summary judgment was granted in favor of the defendants who are healthcare providers. According to the plaintiffs evidence, the decedent’s chance of survival from cancer was eighty percent on the date of the alleged malpractice (failure to order appropriate test and failure to correctly interpret a sonogram) and fifty to sixty percent when appropriate treatment began. The major issue to be decided is whether proof that a healthcare provider was responsible for a twenty- to thirty-percent reduction in the decedent’s chance of survival is sufficient to prove that the malpractice caused the death.1 We shall hold that it is not.
[667] I.
Sherri Schaefer was diagnosed with cancer on April 27, 2001. Beginning in May 2001, Ms. Schaefer was treated for that disease at The Johns Hopkins Hospital in Baltimore. The treatment ultimately was unsuccessful, and she died of cancer on May 18, 2005.
About six months before her death, Ms. Schaefer and her husband, Charles Marcantonio, brought a medical malpractice suit in the Circuit Court for Anne Arundel County against Dr. Melissa Moen, a gynecologist, and the corporation for whom she was acting as an agent, i.e., Women’s OB/GYN, P.A. In their suit, plaintiffs also named as defendants Dr. Paula A. Decandido, a radiologist, and Dr. Decandido’s employer, Anne Arundel Medical Center, Inc.
Shortly after Ms. Schaefer’s death, her husband, individually and as personal representative of Ms. Schaefer’s estate, filed an amended complaint in which he asserted survivorship and wrongful-death claims against the defendants.
The defendants filed a joint motion for summary judgment about eighteen months after the original complaint was filed. The motion was supported by deposition excerpts from three of the expert witnesses named by the plaintiff. The basis for the summary judgment motion was that, according to the defendants, the plaintiff could not prove that any act of negligence on the part of any defendant proximately caused Ms. Schaefer’s death.
The plaintiff filed a timely opposition to the motion that was supported by additional deposition excerpts, together with two affidavits. One affidavit was from Dr. Francis Hutchins, a gynecologist, and the second was from Dr. Barry Shmookler, a pathologist.
Counsel for Dr. Moen and Women’s OB/GYN, P.A., the defendants against whom Dr. Hutchins’ affidavit was directed, filed a motion to strike Dr. Hutchins’ affidavit on the ground that it was inconsistent with his prior deposition testimony. Anne Arundel Medical Center and Dr. Decandido made an [668] oral motion to strike the affidavit of Dr. Shmookler at a hearing held on July 27, 2006.
After hearing arguments of counsel, the circuit court struck the affidavits of Dr. Hutchins and Dr. Shmookler because, in the court’s view, the affidavits were in conflict with the testimony previously given by affiants at deposition. Additionally, the court granted summary judgment against the plaintiff and in favor of all defendants on the ground that plaintiff could not prove that the negligence of the defendants proximately caused Ms. Schaefer’s death.
In this appeal, the plaintiff-appellant claims that the trial court erred in (1) granting summary judgment in favor of the defendants and (2) striking the affidavits of Drs. Hutchins and Shmookler.
II.
Ms. Schaefer was a gynecological patient of Dr. Moen from 1986 through April 27, 2001. Following the onset of menopause in 2000, Ms. Schaefer was treated by Dr. Moen with cyclic hormone replacement therapy (“HRT”), a treatment that provokes a monthly shedding of the uterine lining. A patient going through menopause will continue to have periodic bleeding resembling a menstrual cycle when undergoing cyclic HRT.
During an office visit on August 27, 2000, Ms. Schaefer complained of heavier than normal vaginal bleeding. Dr. Moen ordered a sonogram to find out the cause of the problem.
The sonogram was performed on September 11, 2000, at Anne Arundel Medical Center and was interpreted by Dr. Decandido. At that point, the sonogram film revealed nothing abnormal in the uterus. Plaintiff alleged in his complaint that Dr. Decandido was liable for medical malpractice because she failed to report a 1.5 cm mass arising from the right ovary that was shown on the sonogram. As to Dr. Decandido and her employer, appellant asserted that, if the 1.5 cm mass had been reported in September 2000 to Dr. Moen, then appropri[669] ate additional tests would have been performed that would have resulted in Ms. Schaefer’s undergoing a total hysterectomy at that time.
The allegation of medical malpractice against Dr. Moen and Women’s OB/GYN, P.A., was that in late August 2000 Dr. Moen should have ordered, but did not, an endometrial biopsy,2 which is a test to sample the lining of the uterus.3 Appellant’s theory of malpractice against Dr. Moen was that if Dr. Moen had ordered an endometrial biopsy in August of 2000, the biopsy would have shown either overt cancer or complex hyperplasia with atypia4 The proper treatment for both of these abnormalities is a total abdominal hysterectomy. The plaintiff claimed in his complaint that if Ms. Schaefer had had a total hysterectomy in September 2000 she would not have died of cancer.
Dr. Moen treated Ms. Schaefer for seven months after she ordered the sonogram. On April 27, 2001, following another episode of heavy vaginal bleeding, Dr. Moen recommended an endometrial biopsy. Ms. Schaefer consented to the biopsy, and it was performed that day in Dr. Moen’s office. The biopsy revealed that the patient had endometrial cancer (i.e., uterine cancer).
Shortly after that diagnosis, in early May 2001, Ms. Schaefer underwent treatment provided by Dr. Robert Bristow, a gynecological oncologist.
[670] The defendants, in their motion for summary judgment, contended that, in a complex medical malpractice case of this sort, the plaintiff needed a medical expert to prove that the alleged acts of malpractice proximately caused Ms. Schaefer’s death. But, according to defendants, the depositions of plaintiffs own experts demonstrated that plaintiff could not prove proximate cause. In support of their motion, the defendants relied upon the deposition testimony of three witnesses named by plaintiff as expert witnesses, i.e., Dr. Robert Bristow, Dr. Francis Hutchins, and Dr. Barry Shmookler.
III.
A. Deposition of Dr. Robert Bristow
Free access — add to your briefcase to read the full text and ask questions with AI
SALMON, J.
This case arises out of a survivorship/wrongful-death lawsuit in which summary judgment was granted in favor of the defendants who are healthcare providers. According to the plaintiffs evidence, the decedent’s chance of survival from cancer was eighty percent on the date of the alleged malpractice (failure to order appropriate test and failure to correctly interpret a sonogram) and fifty to sixty percent when appropriate treatment began. The major issue to be decided is whether proof that a healthcare provider was responsible for a twenty- to thirty-percent reduction in the decedent’s chance of survival is sufficient to prove that the malpractice caused the death.1 We shall hold that it is not.
[667] I.
Sherri Schaefer was diagnosed with cancer on April 27, 2001. Beginning in May 2001, Ms. Schaefer was treated for that disease at The Johns Hopkins Hospital in Baltimore. The treatment ultimately was unsuccessful, and she died of cancer on May 18, 2005.
About six months before her death, Ms. Schaefer and her husband, Charles Marcantonio, brought a medical malpractice suit in the Circuit Court for Anne Arundel County against Dr. Melissa Moen, a gynecologist, and the corporation for whom she was acting as an agent, i.e., Women’s OB/GYN, P.A. In their suit, plaintiffs also named as defendants Dr. Paula A. Decandido, a radiologist, and Dr. Decandido’s employer, Anne Arundel Medical Center, Inc.
Shortly after Ms. Schaefer’s death, her husband, individually and as personal representative of Ms. Schaefer’s estate, filed an amended complaint in which he asserted survivorship and wrongful-death claims against the defendants.
The defendants filed a joint motion for summary judgment about eighteen months after the original complaint was filed. The motion was supported by deposition excerpts from three of the expert witnesses named by the plaintiff. The basis for the summary judgment motion was that, according to the defendants, the plaintiff could not prove that any act of negligence on the part of any defendant proximately caused Ms. Schaefer’s death.
The plaintiff filed a timely opposition to the motion that was supported by additional deposition excerpts, together with two affidavits. One affidavit was from Dr. Francis Hutchins, a gynecologist, and the second was from Dr. Barry Shmookler, a pathologist.
Counsel for Dr. Moen and Women’s OB/GYN, P.A., the defendants against whom Dr. Hutchins’ affidavit was directed, filed a motion to strike Dr. Hutchins’ affidavit on the ground that it was inconsistent with his prior deposition testimony. Anne Arundel Medical Center and Dr. Decandido made an [668] oral motion to strike the affidavit of Dr. Shmookler at a hearing held on July 27, 2006.
After hearing arguments of counsel, the circuit court struck the affidavits of Dr. Hutchins and Dr. Shmookler because, in the court’s view, the affidavits were in conflict with the testimony previously given by affiants at deposition. Additionally, the court granted summary judgment against the plaintiff and in favor of all defendants on the ground that plaintiff could not prove that the negligence of the defendants proximately caused Ms. Schaefer’s death.
In this appeal, the plaintiff-appellant claims that the trial court erred in (1) granting summary judgment in favor of the defendants and (2) striking the affidavits of Drs. Hutchins and Shmookler.
II.
Ms. Schaefer was a gynecological patient of Dr. Moen from 1986 through April 27, 2001. Following the onset of menopause in 2000, Ms. Schaefer was treated by Dr. Moen with cyclic hormone replacement therapy (“HRT”), a treatment that provokes a monthly shedding of the uterine lining. A patient going through menopause will continue to have periodic bleeding resembling a menstrual cycle when undergoing cyclic HRT.
During an office visit on August 27, 2000, Ms. Schaefer complained of heavier than normal vaginal bleeding. Dr. Moen ordered a sonogram to find out the cause of the problem.
The sonogram was performed on September 11, 2000, at Anne Arundel Medical Center and was interpreted by Dr. Decandido. At that point, the sonogram film revealed nothing abnormal in the uterus. Plaintiff alleged in his complaint that Dr. Decandido was liable for medical malpractice because she failed to report a 1.5 cm mass arising from the right ovary that was shown on the sonogram. As to Dr. Decandido and her employer, appellant asserted that, if the 1.5 cm mass had been reported in September 2000 to Dr. Moen, then appropri[669] ate additional tests would have been performed that would have resulted in Ms. Schaefer’s undergoing a total hysterectomy at that time.
The allegation of medical malpractice against Dr. Moen and Women’s OB/GYN, P.A., was that in late August 2000 Dr. Moen should have ordered, but did not, an endometrial biopsy,2 which is a test to sample the lining of the uterus.3 Appellant’s theory of malpractice against Dr. Moen was that if Dr. Moen had ordered an endometrial biopsy in August of 2000, the biopsy would have shown either overt cancer or complex hyperplasia with atypia4 The proper treatment for both of these abnormalities is a total abdominal hysterectomy. The plaintiff claimed in his complaint that if Ms. Schaefer had had a total hysterectomy in September 2000 she would not have died of cancer.
Dr. Moen treated Ms. Schaefer for seven months after she ordered the sonogram. On April 27, 2001, following another episode of heavy vaginal bleeding, Dr. Moen recommended an endometrial biopsy. Ms. Schaefer consented to the biopsy, and it was performed that day in Dr. Moen’s office. The biopsy revealed that the patient had endometrial cancer (i.e., uterine cancer).
Shortly after that diagnosis, in early May 2001, Ms. Schaefer underwent treatment provided by Dr. Robert Bristow, a gynecological oncologist.
[670] The defendants, in their motion for summary judgment, contended that, in a complex medical malpractice case of this sort, the plaintiff needed a medical expert to prove that the alleged acts of malpractice proximately caused Ms. Schaefer’s death. But, according to defendants, the depositions of plaintiffs own experts demonstrated that plaintiff could not prove proximate cause. In support of their motion, the defendants relied upon the deposition testimony of three witnesses named by plaintiff as expert witnesses, i.e., Dr. Robert Bristow, Dr. Francis Hutchins, and Dr. Barry Shmookler.
III.
A. Deposition of Dr. Robert Bristow
When Dr. Bristow first saw Ms. Schaefer as a patient in May 2001, she had Stage 3C endometrial cancer. He operated on Ms. Schaefer in June 2001. Thereafter, he was her treating physician at The Johns Hopkins Hospital until her death. According to Dr. Bristow, Ms. Schaefer’s cancer treatment was “fairly proactive and aggressive.” He testified that, assuming a “fairly proactive and aggressive treatment approach,” Ms. Schaefer had, at the time he operated on her in June 2001, a fifty- to sixty-percent chance of survival.
Dr. Bristow’s exact testimony in regard to the chances of survival was as follows:
Q. And do you know what the survivability is for patients with 3C endometrial cancer?
A. Yes.
Q. What is that?
A. I mean, in general. Based on our experience and based on the literature.
Q. Based on your experience and the literature, what is the prognosis for 3C endometrial cancer?
A. Well, there’s quite a range. It depends on the therapeutic treatment program, in many instances, and so there are some reports in the — in the literature of survivability range anywhere from thirty percent all the way up to [671] eighty-five percent, with a general average probably being somewhere in the fifty to sixty-five or seventy-five percent for a five-year survival. That’s assuming a fairly proactive and aggressive treatment approach.
Q. Did Ms. Schaefer get a fairly proactive and aggressive treatment approach?
A. I would say that she did, yes.
Q. In the medical records, there is a note of your discussing with Ms. Schaefer that her chances of survival following the surgery, and assuming she accepted the proactive and aggressive treatment you were recommending, were in the fifty to sixty percent range. Is that accurate?
A. I think that’s a pretty fair estimate, yes.
(Emphasis added.)
Dr. Bristow was unable to say, one way or the other, whether Ms. Schaefer had metastatic cancer in September of 2000 when the sonogram was performed. In this regard, he said at deposition:
Q. But you’re not able to say at what point in time she first had cancer?
A. Well, I can say that we diagnosed it when she had a major surgical operation here, and as I said, I believe it was in — I think it was in June of 2001. At the advanced stage that her cancer had presented, it had been growing for some period of time prior so that in order to achieve that degree of advanced stage.
Q. Okay.
A. It’s very difficult to put a time estimate on how long that would have occurred, because cancers will vary in their growth rate, so it could have been anywhere from months to even years.
Q. Okay. And is it accurate to state that you can’t say within reasonable medical probability at what point in time she had metastatic cancer?
A. Other than to say that at the time of the surgery that we did, it was pretty clear that she had metastatic cancer, [672] but I’m unable to say at what point prior to that the metastatic cancer developed.
Q. So you can’t say one way or the other whether she already had metastatic cancer in September of 2000?
A. I think that’s a fair statement.
He summed up his opinion when he said later in his deposition that it was possible that in September 2000 she already had metastatic cancer, but it was also possible that she did not.
B. Deposition of Dr. Francis Hutchins
Dr. Hutchins, a gynecologist, testified that by August 25, 2000, the date of the alleged malpractice by Dr. Moen, he believed that if an endometrial biopsy had been done on that date the biopsy would have shown either: (1) simple hyperplasia of the endometrium, (2) complex hyperplasia of the endometrium with atypia, or (3) early overt cancer. According to Dr. Hutchins, if Ms. Schaefer had simple hyperplasia in August of 2000, the appropriate treatment would have been merely to adjust her hormone replacement therapy regime, which Dr. Moen did on August 25, 2000.5 On the other hand, if the patient had either overt cancer or complex hyperplasia with atypia, the appropriate treatment in early September 2000 would have been total abdominal hysterectomy.
Later in his deposition, Dr. Hutchins testified that, if Ms. Schaefer had cancer of the uterus in early September 2000, the cancer was at Stage 1A, and with proper treatment, her chance of being cured at that point was eighty percent.
Dr. Hutchins responded in the negative when he was asked by defense counsel if he would be “rendering an opinion within reasonable medical probability” as to Ms. Schaefer’s cause of death.
[673] C. Deposition of Dr. Barry Shmookler
Dr. Shmookler, a pathologist, testified that the ovarian mass, which Dr. Decandido did not report, was “in all probability” benign on August 27, 2000, but nevertheless the mass was “a precursor to cancer.” He also opined that Ms. Schaefer had two primary sites of cancer in May 2001: one site in the endometrium (uterine cancer) and the other in the ovary— and that the two cancers grew independently. He testified that in early September 2000 the tumor in the endometrium was then probably either “atypical hyperplasia [hyperplasia with atypia] or carcinoma in situ [cells that are cancerous].” He opined that if Ms. Schaefer’s condition had been properly diagnosed in September 2000, “in all medical probability” her “uterine cancer [i.e., the cancer in the endometrium] would have been curable.”
Dr. Shmookler’s exact testimony in regard to causation was as follows:
Q. Do you have an opinion as to Ms. Schaefer’s prognosis at any point in time from August of 2000 through July of 2001?
A. Well, I believe, at the time of the sonogram, the first sonogram, which was ... September of 2000 — again, as far as the ovary, as I said, we know there was a complex mass there. We also know that it was one to one and a half centimeters. I believe at that point it was, as I said earlier, a cystadenoma, which is a benign tumor, so there is no chance of metastasis there, and I also mentioned that the endometrial tumor [tumor in the uterus] was in a much earlier state, that it was not invasive, it was probably atypical hyperplasia or maybe carcinoma in situ, so I think, had that been diagnosed in September of 2000, in all medical probability that uterine cancer would have been curable.
(Emphasis added.)
Dr. Shmookler also said in his deposition that he had no opinion as to Ms. Schaefer’s prognosis as of May 2001, which [674] was the date she commenced receiving appropriate medical treatment from Dr. Bristow.
IV. PROCEEDINGS IN THE CIRCUIT COURT
When the defendants filed their motion for summary judgment, they relied primarily on the cases of Fennell v. S. Maryland Hosp. Ctr., Inc., 320 Md. 776, 580 A.2d 206 (1990), and Weimer v. Hetrick, 309 Md. 536, 525 A.2d 643 (1987). Movants also stressed Dr. Bristow’s uncontradicted testimony that Ms. Schaefer had a fifty- to sixty-percent chance of survival as of June 2001 when he operated on her. The defendants worded their argument as follows:
Plaintiff has not produced any expert who can say that the [defendants’ alleged negligence was the probable cause of Ms. Schaefer’s death, because no expert in this case can or did opine that the [djefendants deprived Ms. Schaefer of more than a 50% chance of surviving her cancer. Because it is undisputed that she had a 50-60% chance of survival at the time of her initial surgery, which took place after the occurrence of the alleged medical negligence, it is not possible for any expert to opine that the [defendants herein were responsible for a greater than 50% diminution in Ms. Schaefer’s prognosis. It is mathematically impossible. Absent such testimony, [plaintiffs have failed to establish the element of probable cause.
(Emphasis added.)
Counsel for plaintiff countered:
Defendants’ “loss of chance” argument is nothing more than an effort at turning the issue of proximate cause on its head.... [I]t is readily apparent that the instant case is not a “loss of chance” case. As already mentioned, “loss of chance” means “decreasing the chance of survival as a result of negligent treatment where the likelihood of recovery from the preexisting disease or injury, prior to any alleged negligent treatment, was improbable, i.e., fifty percent or less.” Fennell v. Southern Maryland Hosp. Center, Inc., 320 Md. 776, 781 [580 A.2d 206] ... (1990) (emphasis [675] supplied). See also Cooper v. Hartman, 311 Md. 259, 264-65 [533 A.2d 1294] ... (1987) (“loss of chance” applies in cases where, due to the severity of the patient’s preexisting condition, the plaintiff has difficulty proving causation, i.e., difficulty demonstrating “a better than even chance of recovery, absent the malpractice”); Weimer v. Hetrick, 309 Md. 536 [525 A.2d 643] ... (1987) (finding no error in trial court’s charge to the jury that, if prior to any malpractice by the defendant the premature infant’s chance of survival was 50% or less, the jury must find in favor of the defendant).
Whatever chance of survival Ms. Schaefer had at the time of the correct diagnosis in May of 2001 is irrelevant for purposes of a “loss of chance” analysis. Instead, the Court must focus on her prognosis when [defendants failed to properly diagnose her condition in August and September of 2000, at which time the evidence demonstrates that, but for [defendants’ negligence, Ms. Schaefer would have been cured of cancer and would be alive today.